Gå till forskningen.

Publikationsdata från Europe PMC och PubMed. Följ källhänvisningar från ämnesregistret till originalpublikationerna.

Publikationer som ChEBI hänvisar till för PQIP. Visa hela publikationsregistret

En publikationsträff är inte en slutsats. Publikationslistan visar bibliografiska uppgifter. Eventuella forskningsutdrag visas separat med originalunderlag. En källhänvisning visar inte i sig effekt, dosering eller säkerhet.

Publikationer i urvalet

6 träffar

Bibliografisk träff 2013-05-01

Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis.

Logan JG, Sophocleous A, Marino S, Muir M, Brunton VG, Idris AI.

J Bone Miner Res · research support, non-u.s. gov't; journal article · DOI 10.1002/jbmr.1847

Bibliografisk träff 2011-11-19

Pharmacodynamic modeling of sequence-dependent antitumor activity of insulin-like growth factor blockade and gemcitabine.

Khatri A, Brundage RC, Hull JM, Williams BW, Yee D, Kirstein MN.

AAPS J · comparative study; research support, non-u.s. gov't; research-article; journal article · DOI 10.1208/s12248-011-9308-3

Bibliografisk träff 2011-08-18

Enhancement of doxorubicin cytotoxicity of human cancer cells by tyrosine kinase inhibition of insulin receptor and type I IGF receptor.

Zeng X, Zhang H, Oh A, Zhang Y, Yee D.

Breast Cancer Res Treat · research-article; journal article; research support, n.i.h., extramural · DOI 10.1007/s10549-011-1713-x

Bibliografisk träff 2010-10-13

The insulin-like growth factor I receptor/insulin receptor tyrosine kinase inhibitor PQIP exhibits enhanced antitumor effects in combination with chemotherapy against colorectal cancer models.

Flanigan SA, Pitts TM, Eckhardt SG, Tentler JJ, Tan AC, Thorburn A, Leong S.

Clin Cancer Res · research support, non-u.s. gov't; research-article; journal article; research support, n.i.h., extramural · DOI 10.1158/1078-0432.ccr-10-2054

Bibliografisk träff 2008-06-19

Small-molecule inhibition and activation-loop trans-phosphorylation of the IGF1 receptor.

Wu J, Li W, Craddock BP, Foreman KW, Mulvihill MJ, Ji QS, Miller WT, Hubbard SR.

EMBO J · research-article; journal article; research support, n.i.h., extramural · DOI 10.1038/emboj.2008.116

Bibliografisk träff 2007-08-01

A novel, potent, and selective insulin-like growth factor-I receptor kinase inhibitor blocks insulin-like growth factor-I receptor signaling in vitro and inhibits insulin-like growth factor-I receptor dependent tumor growth in vivo.

Ji QS, Mulvihill MJ, Rosenfeld-Franklin M, Cooke A, Feng L, Mak G, O'Connor M, Yao Y, Pirritt C, Buck E, Eyzaguirre A, Arnold LD, Gibson NW, Pachter JA.

Mol Cancer Ther · journal article · DOI 10.1158/1535-7163.mct-07-0070